講演・口頭発表等 - 森尾　友宏

分割表示  1,051 件中 141 - 160 件目  ／  全件表示 >>

  1. Morio T. . Ataxia-Telangiectasia in Japan:Phenotypic variations in affected siblings with Ataxia-Telangiectasia. . Ataxia-Telangiectasia Workshop 2008. 2008.04 Otsu, Shiga

  2. Morio T. . Immunodefiencies with impaired DNA damage response.. Recent Advances in DNA Damage Response. 2008.04

  3. Mizutani S, Unno J, Watanabe F, Takagi M ,Morio T, Teraoka H, Domenico D.. Regulation of Artemis/ATM-related DNA damage response network.. Ataxia-Telangiectasia Workshop 2008. 2008.04 Otsu, Shiga,

  4. Nakamura K, Morio T, Mizutani S,. Identification of Novel Mutation in Japanese Patients with Ataxia Telangiectasia ; Absence of Founder Mutations.. Ataxia- TelangiectasiaWorkshop 2008. 2008.04 Otsu, Shiga,

  5. Unno J, Takagi M, Watanabe F, Sato M, Takahashi N, Morio T, Teraoka H, Mizutani S. . Generation of DNA double-stranded breaks in stalled DNA replication forks: an essential step initiated by Artemis toward a second wave of DNA damage response and ATM activation.. Ataxia-Telangiectasia Workshop 2008. 2008.04 Otsu, Shiga,

  6. Watanabe F, Morio T, Ogigami N, Kiyono T, Delia D, Mizutani S.. Stability of Artemis protein is regulated by Hsp72. . Ataxia-Telangiectasia Workshop 2008. 2008.04 Otsu, Shiga,

  7. Morio T. . Strategy to combat opportunistic infections after umbilical cord stem cell transplantation.. The 5th Annual International Umbilical Cord Blood Transplantation Symposium. 2007.05 California, USA.

  8. Morio T. . Immunity & Nutrition, Its importance in post-transplantation period.. Symposium on Infection, Immunity and Nutrition. 2007.03 Seoul, Korea

  9. Morio T. . Strategy to combat opportunistic infections aft Seoul, Korea.er stem cell transplantation. . The 11th Congress of Asian-Pacific Bone Marrow Transplantation. 2006.10 Nagoya, Japan.

  10. Morio T. . Cell cycle checkpoint. DNA repair system. and Carcinogenesis. . International Symposium on Gastrointestinal Disorders: Molecular Mechanisms of Pathogenesis. in Commemoration of 120th Anniversary of Yonsei Univeisity. College of Medicine. 2005.06 Seoul, Korea.

  11. Morio T. . Activated T-Cell Transfusion for Opportunistic Infection in Immunodeficient Patients and for Post-transplant Infections.. The 2nd International Symposium "New Challenges in the Post Genome Era 2003" 2003.11 Seoul, Korea.

  12. Morio T. . Activated T-Cell transfusion for opportunistic infection in immunodeficient patients and for post-transplant infections.. The 10th Meeting of Transplantation/ Immunoregulation 21. 2003.11 Tokyo, Japan.

  13. Morio T. . Activated T-Cell Transfusion for Opportunistic Infection in Immunodeficient Patients.. Nihon University School of Medicine Symposium “Cell Biology of Virus Infection” 2003.10 Tokyo, Japan.

  14. Morio T. . Molecular Basis of Primary Immunodeficiency.. The 46th Meeting of Korean Association of Immunobiologists 2003.04 Seoul, Korea.

  15. Morio T. . Ku70/80, A DNA Repair Protein Involved in Cellular Survival, Transformation, and Death.. 2002 International Symposium on Exocrine Pancreas 2002.08 Seoul, Korea.

  16. Morio T. . Proteomics approach for elucidating signal transduction pathway. Symposium: "Genomics and Proteomics in Pharmacology" . Annual Meeting of Korean Society of Pharmacology 2001.04 Seoul, Korea.

  17. Morio T. . Proteomics approach for elucidating signal transduction pathway. Symposium: "Genomics and Proteomics in Pharmacology". Annual Meeting of Korean Society of Pharmacology 2001.04 Seoul, Korea.

  18. Morio T. . Identification of CD40-associated protein by protein microsequencing and ESI-MS.. In Proteomics and Genomics in Biotechnology, The 8th Bioproduct Research Center International Symposium. 2000.06 Seoul, Korea.

  19. 森尾友宏. 治療抵抗性感染症に対するウイルス特異的T細胞療法. 造血幹細胞移植後の合併症に関する研究会 2025.08.01 大阪

  20. 森尾友宏. Inborn Errors of Immunityにおける現状と課題、最新の治療. IEI Seminar 2025.07.17 東京

< 前のページ - 次のページ >

このページの先頭へ▲